๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib

โœ Scribed by Jiri Horak; Jeff White; Adrian L. Harris; Mark Verrill; James Carmichael; Alison Holt; Mireille Cantarini; Merran Macpherson; Alan Swaisland; Helen Swaisland; Chris Twelves

Publisher
Springer
Year
2011
Tongue
English
Weight
331 KB
Volume
68
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Effect of mild and moderate hepatic impa
Effect of mild and moderate hepatic impairment on azimilide pharmacokinetics following single dose oral administration
โœ Alfred E. Corey; Jeffrey R. Agnew; Eileen C. King; Nikhil J. Parekh; James H. Po ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

Azimilide dihydrochloride (75-125 mg/day) is currently being developed for use in prolonging the time to recurrence of atrial fibrillation/flutter and for reducing the frequency of shocks in patients with an implantable cardioverting defibrillator. This study investigated the influence of mild and m